参考文献

1．Grieg PD,Woolf GM,Sinclair T etal.Treatment of primary Liver grafts nonfunction with prostaglandinE1.Transplantation,1989,48:447 2.LangeR,Erhard J,Rauen U et al.Determination of hepatocellular enzymes in effluent ofhuman liver grafts for preoperative evaluation of transplantquality.Transplantation,1996,62:1255 3.RelaM,Muiesan P,Bhatnagar V et al .Hepatic artery thrombosis after livertransplantation in children under 5years ofl age.Transplantation ,1996,61:1355 4.DrazanK,Shaked A,Olthof KM et al .Etiology and management of symptomatic adulthepatic artery thrombosis after orthotopic liver transplantation(OLT).AmSurg,1996,62:237 5.JurimO,Csete M,Gelabert HA et al.Reduced-sized graft-the solution for heparic arterythrombosis after pediatric liver transplantation?J Pediatr Surg,1995,30:53 6 MillisJM,Seaman DS,Piper JB et al.Portal vein thrombosis and stenosis in pediatricliver transplantation.Transplantation,1996,62:748 7Bhatnagar V,Dhawan A,Chaer H et al.The incidence and management of biliarycomplications following liver transplantation in chhldren,Transpl Int,1995,8:38 8Macfarlane B,Davidson B,Dooley JS et al.Endoscopic retrograde cholangiographyin the diagnosis and endoscopic management op biliary complications.Eur JGastroenterol Hepatol,1996,8:1003 9 KhongPL,Sreeram N,John PR.Metallic sterting of biliary free following livertransplant hepatic artery thrombosis in an infant.Pediatr Rediol,1997,27:79 10Douzdjian V,Abecassis MM,Johlin FC.Sphincter of Oddi dysfunction followingliver transplantation.Screening by bedside mainometry and definitive manometricevaluation.Dig Dis Sci,1994,39:253 11Haagsma EB,Thijn CJ,Post JG et al.Bone disease after orthotopictransplantation,J Hepatol,1988,6:94 12Stegall MD,Everson G,Schroter G et al.Metabolic complication after livertransplantation:diabetes,hypercholesterolemia,hypertension,andobesity,Transplantation,1995,60:1057 13 PallerMC.The prostaglandin E1analogue,misoprostol analogue reverses acutecyclosporine nephrotoxicity.Transplant Proc,1988,20(Suppl 3):634 14Wijdicks EF Wiesner RH,Krom RA.Neurotoxity in liver transplant recipients withcyclosporine immnosuppression.Neurology,1995,45:1962 15 KabeerMH,Filo RS,Milgrom ML et al.Central pontine myelinolysis following orthotopicliver transplantation:association with cyclosporine toxicity.Postgrad MedJ,1995,71:834;71:239 16 FryerJP,Fortier MV,Metrakos P et al.Central pontine myelinolysis and cyclosporineneurotoxicity following liver transplantation,Transplantation,1996,61:658 17Falagas ME,snydman DR,Griffith J et al.Effect of cytomegalovirus infectionstatus or first-year mortality.Boston Center for Liver Transplantation CMV IgGStudy Gfroup.Ann Intern Med,1997,126:275 18Vandenberg AP,Klompmaker IJ,Haagsma EB et al.Evidence for an increased rate ofbacterial infections in liver transplant patients with cytomegalovirusinfection,Clin Transplant,1996,10:224 19Falagas ME,Snydman DR,Ruthaxer R et al.Primary cytomegalovirus infection inliver transplant recipients:comparison of infections transmitted via donororgans and via transfusions.Boston Center for liver Transplantation CMV IgGStudy Group.Clin Infect Dis,1996,23:292 20 WinstonDJ,wirin D,Shaked A et al.Randomized comparison of gancyclovir and high-doseacyclovir for long-term cytomegalovirus prophylaxis in liver transplantrecipients.Lancet.1995,346:8967 21 KanjSS,Sharara AI,Clavien PA et al.Cytomegalovirus infection following livertransplantation:review of the literature.Clin Infect Dis,1996,22:537 22Stratta RJ,Shaefer MS,Cushing KA et al.A randomized prospective trial ofacyclovir and immune globulin prophylaxis in liver transplant recipientsreceiving OKT3 therapy,Arch Surg,1992,127:55 23 LiebauP,Kuse E,Windler M er al.Management of herpes simples virus type l pneumoniafollowing liver transplantation,Infection,1996,24:130 24Lumbreras C,Cuervas-Mons V,Jara p et al,Randomized study of candida infectionfollowing liver transplantation,j Infect Dis,1996,174;583 25Torre-C,Cuervas-Mons V,Jara P et al.Effective of daily low-dose cotrimoxazoleprophylaxis for Pneumocystis carinii pneumonia in liver transplantation- anopen clinical trail.Transplantation,1996,62:1519 26 LynchSV,Strong RW.Primary cirrhosis:does it recur after transplantation?JGastroenterol Hepatol,1989,4:109 27Anon.Is PBC cured by liver transplantation?Lancet,1991,337:272 28 KnoopM,Bechstein WO,Schrem H et al.Clinical Significance of recurrent primarybiliary cirrhosis after liver transplansplantation.Transpl Int,1996,9(Suppl1):S115 29 Van DEWater J,Gerson LB,Ferrell LD et al.Immunohistochemical evidence of diseaserecurrence after liver transplantation for primary biliary cirrhosis.Hepatology,1996,24:1079 30 SebaghM,Farges O,Kalil A et al.Sclerosing cholangitis following human orthotopicliver transplantation.Am J Surg pathol,1995,19:81 31 DevlinJ,Donaldson P,Portmann B et al.Recurrence of autoimmmune hepatitis followingliver transplantation,Liver Transplant Surg,1995,1:162 32 O＇Grady JG,Williams R,Livertransplantation for viral hepatitis.Br Med Bull,1990,46:481 33 HartJ,Busuttil RW,Lewin KJ.Disease recurrence following liver transplantation.Am JSurg Pathol,1990,14(Suppl 1):79 34Terrault NA,Zhou S,Combs C et al.Prophylaxis in liver transplant recipientsusing a fixed dosing schedule of hepatitisBimmunoglobulin.Hepatology,1996,24:1327 35 McGoryRW,Ishitani MB,Oliveira WM et al.Imprived ortcome of orthotopic liver transplantationfor chromic hepatitis B cirrhosis with aggressive passiveimmunization.Transplantation,1996,61:1358 36 BainVG,Kneteman NW,Ma MM et al.Efficacy of lamivudine im chronic hepatitis Bpatients with active viral replication and decompensated cirrhosis undergongliver transplantation,Transplantation,1996,62:1456 37Grdllier L,Mutimer D,Ahmed M et al.Lamivudine prophylaxis against reinfectionin liver transplantation for hepatitis B cirrhosis.Lancet,1996,348:9036 38Ben-Ari Z,Shmueli D,Mor E et al.Beneficial effect of lamivueine in recurrenthepatitis b after liver transplantation.Transplantation,1997,63:393 39Bartholomew MM,Jansen RW,Jeffers LJ et al.Hepatitis-B-virus resistance tolamivudine given for recurrent infection after orthotopic livertransplantation.Lancet,1997,349:9044 40 GishRG,Lau JY,Brook L at al.Gancyclovir treatment of hepatitis B virus infection inliver transplant recipients.Hepatology,1996,23:1 41 BokerKH,Ringe B,Kroger M et al.Prostaglandin plus famciclovir-a new concept for thetreatment of sever hepatitis B after liver transplantation.Transplantation,1994,57:1706 42HallerGW,Bechstein WO,Neuhaus R et al.Famciclivir therapy for recurrent hepatitis Binfection after transplantation.Transpl Int,1996,9(Suppl 1):S210 43NeuhausP,Steffer R,Blumhardt G et al.Experience with immunoprophylaxis and interferontherapy after liver transplantation in HBsAg-positive patients.TransplantProc,1991,23:1522 44Cavallari A,Vivarelli M,D[SB]’[/SB]Errico A et al.Fatal necrotizing pancreatitiscaused by hepatitis B infection in a liver transplant recipients.JHepatol,1995,22:685 45Schluger LK,Sheiner PA,Thung SN et al.Severe recurrent cholestatic hepatitis Cfollowing orthotopic liver transplantation.Hepatology,1996,23:971 46 GaneEJ,Tibbs CJ,Ramage Jk et al.Ribavirin therapy for hepatitis C infectionfollowing liver transplantation.Transpl Int,1995,8:61 47Cattral MS,Krajden M,Wanless IR et al.A pilot study of ribavirin therapy forrecurrent hepatitis C virus infection after liver transplantation.Transplantation,1996,61:1483 48 FerayC,Samuel D,Gigou M et al.An open trial of interferon alfa recombinant forhepatitis c after liver transplantation:antiviral effects and risk ofrejection.Hepatology,199,22:1084 49Skannal DG,Dunngy-Poythress LJ,Miodovnik M et al.Pregnancy in a combined liverand kidney transplant recipient with type 1 primary hyperosaluria.ObstetGynecol,1995,86:641 50 LaiferSA,Guido RS.Reproductive function and outcome of pregnancy after livertransplantation in women.Mayo Clin Proc,1995,70:388 51Killenberg PG,Clavien PA.Medical care of the liver transplant patientMassachusetts:Blackwell Sciemce Inc,1997:159